文献速递炎症性肠病消化道肿瘤与早癌消化内镜

非整倍体与平坦型异型增生相关并预测炎症性肠病患者发生高级别异型增生或结直肠癌

Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.
PubMed 文献 · Gastroenterology · 2017-08-24

该回顾性分析对1990至2015年在加州大学旧金山医学中心因炎症性肠病接受监测性结肠镜检查的37例患者的平坦型低级别异型增生(fLGD)福尔马林固定石蜡包埋结肠组织进行流式细胞术检测,发现15例(40.5%)存在非整倍体。中位随访37个月,fLGD合并非整倍体患者后续发生高级别异型增生或结直肠癌的单变量风险比为5.3(95%CI 1.542-24.121)。

要点

  • 37例fLGD样本中15例(40.5%)检出非整倍体。
  • 平坦型高级别异型增生样本15例中14例(93.3%)检出非整倍体。
  • fLGD合并非整倍体者后续HGD或结直肠癌风险比为5.3(95%CI 1.542-24.121)。

核心结论

  • 非整倍体的存在可识别fLGD患者中后续发生高级别异型增生或结直肠癌风险增加的人群。
  • 非整倍体检测或可为平坦型高级别异型增生的形态学印象或怀疑提供支持性证据。

研究设计与样本

  • 回顾性分析1990至2015年在加州大学旧金山医学中心因炎症性肠病接受监测性结肠镜检查的37例患者的福尔马林固定石蜡包埋结肠fLGD组织。
  • 对石蜡包埋结肠组织进行流式细胞术分析以检测非整倍体,并收集患者医疗数据,平均随访37个月。

主要发现

  • 37例fLGD样本中15例(40.5%)检出非整倍体。
  • 15例平坦型高级别异型增生样本中14例(93.3%)检出非整倍体。
  • 45例无异型增生样本中2例(4.4%)检出非整倍体。
  • fLGD合并非整倍体患者后续检出高级别异型增生或结直肠癌的单变量风险比为5.3(95%CI 1.542-24.121),平均随访37个月。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is controversy over how to best manage patients with inflammatory bowel disease and flat low-grade dysplasia (fLGD) in the colon. We performed a retrospective analysis of formalin-fixed paraffin-embedded colon tissues with fLGD from 37 patients undergoing surveillance colonoscopy for inflammatory bowel disease from 1990 to 2015 at the University of California at San Francisco Medical Center, to determine whether detection of aneuploidy is associated with later development of high-grade dysplasia (HGD) or colorectal cancer. Medical data were collected from the patients for a mean follow-up time of 37 months. Using flow cytometry analysis of paraffin-embedded colon tissue, we detected aneuploidy in 15 of 37 samples with fLGD (40.5%). By comparison, aneuploidy was detected in 14 of 15 samples with flat HGD (93.3%) and 2 of 45 samples that were negative for dysplasia (4.4%). The univariate hazard ratio for subsequent detection of HGD or colorectal cancer in patients with fLGD and aneuploidy was 5.3 (95% CI, 1.542-24.121) within a mean follow-up time of 37 months. The presence of aneuploidy therefore identifies patients with fLGD in colon tissue who have an increased risk for HGD or colorectal cancer and may provide supportive evidence to a morphologic impression or suspicion of flat HGD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Tsai JH, Rabinovitch PS, Huang D, et al. Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease. Gastroenterology. 2017. PMID: 28843957. doi:10.1053/j.gastro.2017.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。